About MedManage Systems
MedManage Systems, Inc. aims to provide drug sampling solutions. The company's OmniSampleSM Solution aims to allow pharmaceutical companies to intensify physician use of trial medications, thereby increasing product revenues.
Missing: MedManage Systems's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: MedManage Systems's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing MedManage Systems
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
MedManage Systems is included in 2 Expert Collections, including Pharma Supply Chain.
Pharma Supply Chain
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
MedManage Systems Frequently Asked Questions (FAQ)
When was MedManage Systems founded?
MedManage Systems was founded in 1999.
Where is MedManage Systems's headquarters?
MedManage Systems's headquarters is located at 3303 Monte Villa Parkway, Bothell.
What is MedManage Systems's latest funding round?
MedManage Systems's latest funding round is Series E.
How much did MedManage Systems raise?
MedManage Systems raised a total of $41.25M.
Who are the investors of MedManage Systems?
Investors of MedManage Systems include Prism VentureWorks, Versant Ventures, Lilly Ventures, QuestMark Partners, Tredegar and 6 more.
Who are MedManage Systems's competitors?
Competitors of MedManage Systems include MonoSol Rx, Sagent Pharmaceuticals, Catalent, Quinnova Pharmaceuticals, Glide Pharma and 11 more.
Compare MedManage Systems to Competitors
Glide Pharma, formerly Caretek Medical, is a specialty pharmaceutical company developing products for easy, safe and convenient delivery of pharmaceuticals and vaccines using its Glide SDI - the Solid Dose Injector. By being much less invasive than traditional injection methods, Glide improves the treatment experience of both patients and carers and, by allowing the injection of solid formulations, opens up a wide range of therapeutic options for new and existing treatments.
Next Breath, LLC is a contract pharmaceutical research and development organization dedicated to pre-clinical identification and evaluation of commercially viable respiratory and nasal drug delivery platforms. NB's business will discover and exploit optimal drug and delivery device combinations that will increase the company's partners' probability of success when their products advance into human clinical trials and the marketplace. Next Breath seeks to meet the pharmaceutical industry's outsourcing needs and to provide intellectual expertise to biotechnology companies that are developing inhalation products.
Core Tech Solutions, Inc. is engaged in the development of Transdermal, Dermal and Tran mucosal Delivery Systems for the treatment of a variety of indications. The primary mission of the company is to provide transdermal drug delivery development to the worlds pharmaceutical companies. In addition to offering research and development on a contractual basis, Core Tech Solutions possesses the facilities and expertise to perform or coordinate all other aspects of commercialization including Feasibility Studies, Prototype Development, Formulation Optimization, Clinical Trials, Regulatory Compliance, Process Scale-up, and Full Scale Manufacturing.
Kucera Pharmaceutical Company is based in Winston-Salem, NC. The company started with a drug delivery approach that combined or conjugated delivery molecules with therapeutic molecules as a platform technology, both to improve the properties of the attached therapeutic molecules (making them orally available and improving distribution) and to extend patent life.
FORMAC is a pharmaceutical R&D company engaged in drug delivery and development. The firm aims to increase pharmaceutical R&D productivity and product value by enhancing the performance of (pre)clinical drug candidates and marketed drugs.
Pharmaceutical company focused on applying its oral drug delivery platform to develop products with improved therapeutic profiles
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.